![$27 million to unlock the power of genomics – Rare Cancers Australia](https://oncodaily.com/pub/uploads/2024/06/IMG_0405-1280x1065.jpeg)
Photo from Rare Cancers Australia/LinkedIn
Jul 3, 2024, 09:17
$27 million to unlock the power of genomics – Rare Cancers Australia
Rare Cancers Australia shared a post on LinkedIn:
“We welcome Health Minister the Honorable Mark Butler MP’s announcement yesterday of more than $27 million to unlock the power of genomics.
The funding will go towards eight projects intended to improve cancer detection and treatment using genomics, aiming to:
- detect and diagnose cancer earlier
- better identify types of cancer
- use targeted therapies to improve outcomes.
The funding, from the Medical Research Future Fund, includes:
- $3 million to the University of Melbourne to work on the next generation of liquid biopsies for breast cancer.
- $1.7 million to Monash University researchers to develop a liquid biopsy for multiple myeloma.
- more than $2.5 million to Macquarie University to develop a liquid biopsy test for melanoma to help determine which patients need further treatment.
- almost $3 million to the Council of the Queensland Institute of Medical Research to investigate findings that every bowel cancer is unique based on its genomic make-up, and to personalise treatments.
- $8 million to develop a national platform to use AI technology in the diagnosis of severe genetic diseases.
It is great news to see this recognition and investment in genomics to transform health outcomes.”
Source: Rare Cancers Australia/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023